Science
Science at Ceregene »
Neurotrophic Factors »
Gene Delivery Technology »
Newsroom
08-05-09: Ceregene Receives Additional
Grant from Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients »
05-27-09: Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease »
11-26-08: Ceregene Announces
Clinical Data from Phase 2 Clinical Trial
of CERE-120 for Parkinson's Disease »
Corporate Office:
9381 Judicial Drive, Suite 130
San Diego, CA 92121
T: 858-458-8800
F: 858-458-8801
© Ceregene. All rights reserved.
9381 Judicial Drive, Suite 130
San Diego, CA 92121
T: 858-458-8800
F: 858-458-8801
© Ceregene. All rights reserved.
